Clinical Trials · NCT04467983
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
- Phase
- Phase 4
- Recruitment status
- Active Not Recruiting
- Sponsor
- Hospital for Special Surgery, New York
- Enrollment
- 70
- Start date
- Feb 2021
- Locations
- 1 site, United States
- Primary endpoint
- Bone mineral density changes at total hip and lumbar spine